Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Alternative oxidase-mediated respiration prevents lethal mitochondrial cardiomyopathy.

Rajendran J, Purhonen J, Tegelberg S, Smolander OP, Mörgelin M, Rozman J, Gailus-Durner V, Fuchs H, Hrabe de Angelis M, Auvinen P, Mervaala E, Jacobs HT, Szibor M, Fellman V, Kallijärvi J.

EMBO Mol Med. 2018 Dec 10. pii: e9456. doi: 10.15252/emmm.201809456. [Epub ahead of print]

2.

Alternative respiratory chain enzymes: Therapeutic potential and possible pitfalls.

Saari S, Garcia GS, Bremer K, Chioda MM, Andjelković A, Debes PV, Nikinmaa M, Szibor M, Dufour E, Rustin P, Oliveira MT, Jacobs HT.

Biochim Biophys Acta Mol Basis Dis. 2018 Oct 17. pii: S0925-4439(18)30389-2. doi: 10.1016/j.bbadis.2018.10.012. [Epub ahead of print]

3.

Alternative Oxidase Attenuates Cigarette Smoke-Induced Lung Dysfunction and Tissue Damage.

Giordano L, Farnham A, Dhandapani PK, Salminen L, Bhaskaran J, Voswinckel R, Rauschkolb P, Scheibe S, Sommer N, Beisswenger C, Weissmann N, Braun T, Jacobs HT, Bals R, Herr C, Szibor M.

Am J Respir Cell Mol Biol. 2018 Oct 19. doi: 10.1165/rcmb.2018-0261OC. [Epub ahead of print]

PMID:
30339461
4.

Expression of the Alternative Oxidase Influences Jun N-Terminal Kinase Signaling and Cell Migration.

Andjelković A, Mordas A, Bruinsma L, Ketola A, Cannino G, Giordano L, Dhandapani PK, Szibor M, Dufour E, Jacobs HT.

Mol Cell Biol. 2018 Nov 28;38(24). pii: e00110-18. doi: 10.1128/MCB.00110-18. Print 2018 Dec 15.

5.

Perturbed Redox Signaling Exacerbates a Mitochondrial Myopathy.

Dogan SA, Cerutti R, Benincá C, Brea-Calvo G, Jacobs HT, Zeviani M, Szibor M, Viscomi C.

Cell Metab. 2018 Nov 6;28(5):764-775.e5. doi: 10.1016/j.cmet.2018.07.012. Epub 2018 Aug 16.

6.

Control of mitochondrial superoxide production by reverse electron transport at complex I.

Robb EL, Hall AR, Prime TA, Eaton S, Szibor M, Viscomi C, James AM, Murphy MP.

J Biol Chem. 2018 Jun 22;293(25):9869-9879. doi: 10.1074/jbc.RA118.003647. Epub 2018 May 9.

7.

A novel mouse Cre-driver line targeting Perilipin 2-expressing cells in the neonatal lung.

Ntokou A, Szibor M, Rodríguez-Castillo JA, Quantius J, Herold S, El Agha E, Bellusci S, Salwig I, Braun T, Voswinckel R, Seeger W, Morty RE, Ahlbrecht K.

Genesis. 2017 Dec;55(12). doi: 10.1002/dvg.23080. Epub 2017 Oct 27.

PMID:
29045046
8.

Two-Way Conversion between Lipogenic and Myogenic Fibroblastic Phenotypes Marks the Progression and Resolution of Lung Fibrosis.

El Agha E, Moiseenko A, Kheirollahi V, De Langhe S, Crnkovic S, Kwapiszewska G, Szibor M, Kosanovic D, Schwind F, Schermuly RT, Henneke I, MacKenzie B, Quantius J, Herold S, Ntokou A, Ahlbrecht K, Braun T, Morty RE, Günther A, Seeger W, Bellusci S.

Cell Stem Cell. 2017 Apr 6;20(4):571. doi: 10.1016/j.stem.2017.03.011. No abstract available.

9.

Broad AOX expression in a genetically tractable mouse model does not disturb normal physiology.

Szibor M, Dhandapani PK, Dufour E, Holmström KM, Zhuang Y, Salwig I, Wittig I, Heidler J, Gizatullina Z, Gainutdinov T; German Mouse Clinic Consortium, Fuchs H, Gailus-Durner V, de Angelis MH, Nandania J, Velagapudi V, Wietelmann A, Rustin P, Gellerich FN, Jacobs HT, Braun T.

Dis Model Mech. 2017 Feb 1;10(2):163-171. doi: 10.1242/dmm.027839. Epub 2016 Dec 14.

10.

Two-Way Conversion between Lipogenic and Myogenic Fibroblastic Phenotypes Marks the Progression and Resolution of Lung Fibrosis.

El Agha E, Moiseenko A, Kheirollahi V, De Langhe S, Crnkovic S, Kwapiszewska G, Szibor M, Kosanovic D, Schwind F, Schermuly RT, Henneke I, MacKenzie B, Quantius J, Herold S, Ntokou A, Ahlbrecht K, Braun T, Morty RE, Günther A, Seeger W, Bellusci S.

Cell Stem Cell. 2017 Feb 2;20(2):261-273.e3. doi: 10.1016/j.stem.2016.10.004. Epub 2016 Nov 17. Erratum in: Cell Stem Cell. 2017 Apr 6;20(4):571.

11.

Succinate Dehydrogenase Supports Metabolic Repurposing of Mitochondria to Drive Inflammatory Macrophages.

Mills EL, Kelly B, Logan A, Costa ASH, Varma M, Bryant CE, Tourlomousis P, Däbritz JHM, Gottlieb E, Latorre I, Corr SC, McManus G, Ryan D, Jacobs HT, Szibor M, Xavier RJ, Braun T, Frezza C, Murphy MP, O'Neill LA.

Cell. 2016 Oct 6;167(2):457-470.e13. doi: 10.1016/j.cell.2016.08.064. Epub 2016 Sep 22.

12.

Diiron centre mutations in Ciona intestinalis alternative oxidase abolish enzymatic activity and prevent rescue of cytochrome oxidase deficiency in flies.

Andjelković A, Oliveira MT, Cannino G, Yalgin C, Dhandapani PK, Dufour E, Rustin P, Szibor M, Jacobs HT.

Sci Rep. 2015 Dec 17;5:18295. doi: 10.1038/srep18295.

13.

Characterization of the platelet-derived growth factor receptor-α-positive cell lineage during murine late lung development.

Ntokou A, Klein F, Dontireddy D, Becker S, Bellusci S, Richardson WD, Szibor M, Braun T, Morty RE, Seeger W, Voswinckel R, Ahlbrecht K.

Am J Physiol Lung Cell Mol Physiol. 2015 Nov 1;309(9):L942-58. doi: 10.1152/ajplung.00272.2014. Epub 2015 Aug 28.

14.

Bronchoalveolar sublineage specification of pluripotent stem cells: effect of dexamethasone plus cAMP-elevating agents and keratinocyte growth factor.

Katsirntaki K, Mauritz C, Olmer R, Schmeckebier S, Sgodda M, Puppe V, Eggenschwiler R, Duerr J, Schubert SC, Schmiedl A, Ochs M, Cantz T, Salwig I, Szibor M, Braun T, Rathert C, Martens A, Mall MA, Martin U.

Tissue Eng Part A. 2015 Feb;21(3-4):669-82. doi: 10.1089/ten.TEA.2014.0097. Epub 2014 Dec 1.

PMID:
25316003
15.

NOA1, a novel ClpXP substrate, takes an unexpected nuclear detour prior to mitochondrial import.

Al-Furoukh N, Kardon JR, Krüger M, Szibor M, Baker TA, Braun T.

PLoS One. 2014 Jul 29;9(7):e103141. doi: 10.1371/journal.pone.0103141. eCollection 2014.

16.

Engineering the alternative oxidase gene to better understand and counteract mitochondrial defects: state of the art and perspectives.

El-Khoury R, Kemppainen KK, Dufour E, Szibor M, Jacobs HT, Rustin P.

Br J Pharmacol. 2014 Apr;171(8):2243-9. doi: 10.1111/bph.12570. Review.

17.

Remodeling and dedifferentiation of adult cardiomyocytes during disease and regeneration.

Szibor M, Pöling J, Warnecke H, Kubin T, Braun T.

Cell Mol Life Sci. 2014 May;71(10):1907-16. doi: 10.1007/s00018-013-1535-6. Epub 2013 Dec 10. Review.

PMID:
24322910
18.

Binding to G-quadruplex RNA activates the mitochondrial GTPase NOA1.

Al-Furoukh N, Goffart S, Szibor M, Wanrooij S, Braun T.

Biochim Biophys Acta. 2013 Dec;1833(12):2933-2942. doi: 10.1016/j.bbamcr.2013.07.022. Epub 2013 Aug 8.

19.

Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF.

Pullamsetti SS, Banat GA, Schmall A, Szibor M, Pomagruk D, Hänze J, Kolosionek E, Wilhelm J, Braun T, Grimminger F, Seeger W, Schermuly RT, Savai R.

Oncogene. 2013 Feb 28;32(9):1121-34. doi: 10.1038/onc.2012.136. Epub 2012 Apr 23.

PMID:
22525277
20.

Oxidative stress during mitochondrial biogenesis compromises mtDNA integrity in growing hearts and induces a global DNA repair response.

Pohjoismäki JL, Boettger T, Liu Z, Goffart S, Szibor M, Braun T.

Nucleic Acids Res. 2012 Aug;40(14):6595-607. doi: 10.1093/nar/gks301. Epub 2012 Apr 15.

21.

The Janus face of OSM-mediated cardiomyocyte dedifferentiation during cardiac repair and disease.

Pöling J, Gajawada P, Lörchner H, Polyakova V, Szibor M, Böttger T, Warnecke H, Kubin T, Braun T.

Cell Cycle. 2012 Feb 1;11(3):439-45. doi: 10.4161/cc.11.3.19024. Epub 2012 Feb 1.

PMID:
22262173
22.

Oncostatin M is a major mediator of cardiomyocyte dedifferentiation and remodeling.

Kubin T, Pöling J, Kostin S, Gajawada P, Hein S, Rees W, Wietelmann A, Tanaka M, Lörchner H, Schimanski S, Szibor M, Warnecke H, Braun T.

Cell Stem Cell. 2011 Nov 4;9(5):420-32. doi: 10.1016/j.stem.2011.08.013.

23.

Nitric oxide-associated protein 1 (NOA1) is necessary for oxygen-dependent regulation of mitochondrial respiratory complexes.

Heidler J, Al-Furoukh N, Kukat C, Salwig I, Ingelmann ME, Seibel P, Krüger M, Holtz J, Wittig I, Braun T, Szibor M.

J Biol Chem. 2011 Sep 16;286(37):32086-93. doi: 10.1074/jbc.M111.221986. Epub 2011 Jul 19.

24.

Induction of smooth muscle cell migration during arteriogenesis is mediated by Rap2.

Pöling J, Szibor M, Schimanski S, Ingelmann ME, Rees W, Gajawada P, Kochfar Z, Lörchner H, Salwig I, Shin JY, Wiebe K, Kubin T, Warnecke H, Braun T.

Arterioscler Thromb Vasc Biol. 2011 Oct;31(10):2297-305. doi: 10.1161/ATVBAHA.111.232835. Epub 2011 Jul 7.

PMID:
21737786
25.

Identification of right heart-enriched genes in a murine model of chronic outflow tract obstruction.

Kreymborg Kg, Uchida S, Gellert P, Schneider A, Boettger T, Voswinckel R, Wietelmann A, Szibor M, Weissmann N, Ghofrani AH, Schermuly R, Schranz D, Seeger W, Braun T.

J Mol Cell Cardiol. 2010 Oct;49(4):598-605. doi: 10.1016/j.yjmcc.2010.07.014. Epub 2010 Jul 27.

PMID:
20673770
26.

TFAM-dependent and independent dynamics of mtDNA levels in C2C12 myoblasts caused by redox stress.

Noack H, Bednarek T, Heidler J, Ladig R, Holtz J, Szibor M.

Biochim Biophys Acta. 2006 Feb;1760(2):141-50. Epub 2006 Jan 5.

PMID:
16439064
27.

Mitochondrial ageing.

Szibor M, Holtz J.

Basic Res Cardiol. 2003 Jul;98(4):210-8. Review.

PMID:
12835950
28.

Serial competitive RT-PCR using multiple standards.

Szibor M, Morawietz H.

Biotechniques. 2002 Oct;33(4):744, 746, 748. No abstract available.

PMID:
12398179
29.

Increased expression of endothelin-converting enzyme-1 in failing human myocardium.

Morawietz H, Goettsch W, Szibor M, Barton M, Shaw S, Hakim K, Zerkowski HR, Holtz J.

Clin Sci (Lond). 2002 Aug;103 Suppl 48:237S-240S.

PMID:
12193094
30.

Angiotensin-converting enzyme inhibitor therapy prevents upregulation of endothelin-converting enzyme-1 in failing human myocardium.

Morawietz H, Goettsch W, Szibor M, Barton M, Shaw S, Hakim K, Zerkowski HR, Holtz J.

Biochem Biophys Res Commun. 2002 Aug 2;295(5):1057-61.

PMID:
12135601
31.

S-Nitrosylation of mitochondrial caspases.

Mannick JB, Schonhoff C, Papeta N, Ghafourifar P, Szibor M, Fang K, Gaston B.

J Cell Biol. 2001 Sep 17;154(6):1111-6. Epub 2001 Sep 10.

32.

Redox control of mitochondrial functions.

Szibor M, Richter C, Ghafourifar P.

Antioxid Redox Signal. 2001 Jun;3(3):515-23. Review.

PMID:
11491662
33.

Increased expression of endothelin-1 and inducible nitric oxide synthase isoform II in aging arteries in vivo: implications for atherosclerosis.

Goettsch W, Lattmann T, Amann K, Szibor M, Morawietz H, Münter K, Müller SP, Shaw S, Barton M.

Biochem Biophys Res Commun. 2001 Jan 26;280(3):908-13.

PMID:
11162610
34.

Deloading of the left ventricle by ventricular assist device normalizes increased expression of endothelin ET(A) receptors but not endothelin-converting enzyme-1 in patients with end-stage heart failure.

Morawietz H, Szibor M, Goettsch W, Bartling B, Barton M, Shaw S, Koerfer R, Zerkowski HR, Holtz J.

Circulation. 2000 Nov 7;102(19 Suppl 3):III188-93.

PMID:
11082385
35.

Regulation of the endothelin system by shear stress in human endothelial cells.

Morawietz H, Talanow R, Szibor M, Rueckschloss U, Schubert A, Bartling B, Darmer D, Holtz J.

J Physiol. 2000 Jun 15;525 Pt 3:761-70.

Supplemental Content

Loading ...
Support Center